ERBB2 c.494A>C ;(p.D165A)

Variant ID: 17-37865625-A-C

NM_004448.2(ERBB2):c.494A>C;(p.D165A)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates.

Acta Pharmaceutica Sinica. B
Shi, Wei W; Li, Wanzhen W; Zhang, Jianxin J; Li, Tiehai T; Song, Yakai Y; Zeng, Yue Y; Dong, Qian Q; Lin, Zeng Z; Gong, Likun L; Fan, Shuquan S; Tang, Feng F; Huang, Wei W
Publication Date: 2022-05

Variant appearance in text: HER2: D165A
PubMed Link: 35646546
Variant Present in the following documents:
  • Main text
View BVdb publication page